History of hepatitis. 2. Identification of epidemic hepatitis;Histoire des hépatites 2. Individualisation de l'hépatite épidémique et grandes hypothèses pathogéniques

Revue du Praticien

Volumn 52, Issue 20, 2002, Pages 2213-2217

  Payen, Jean Louis ^a   Rongières, Michel ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

BLOOD TRANSFUSION; DISEASE TRANSMISSION; HEPATITIS A; HUMAN; INCUBATION TIME; PATHOGENESIS; REVIEW; VACCINATION;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DISEASE OUTBREAKS; FRANCE; HEPATITIS, VIRAL, HUMAN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; PORTRAITS; VACCINATION;

EID: 17744417509     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Chastel C. Ces Virus Qui Détruisent Les Hommes. Paris: Ramsay; 1996.
2. Meyer J. Soixante Ans de Recherche Sur L'étiologie Des Hépatites Infectieuses (19201980) - Considérations Historiques & Épistémologiques Sur la Notion D'agent Viral. Paris: Panthéon-Sorbonne (Paris I); 1992.
3. Willian R. Report on the Diseases in London, Particularly During the Years 1796, 97, 98, 99, 1800. London, 1801.
4. Dieulafoy G. Manuel de pathologie interne. Onziėme ed. Paris: Masson et Cie, 1898.
5. Hinssen M. Ein Beitrag zur Geschichte der Hepatitis-Infectiosa-Epidemien in Europa Vom Ende Des 17. Bis Zur Mitte Des 19. Jahrhundert Düsseldorf, 1966.
6. Bernhreim H. Article ictère. In: Masson (ed.). Dictionnaire Encyclopédique des Sciences Médicales, Déchambre et le Redoullet,4e Série. Paris: Selin et Houzeau, 1889: 388-452.
7. Cockayne E. Catarrhal jaundice sporadic and epidemic, and its relation to acute yellow atrophy of the liver. Q J Med 1912; 6: 1-27.
8. e Ed. Paris: Maloine, 1948.
9. Lürman A. Eine Icterusepidemie. Berliner Klin Wochensch 1885; 22: 20-7.
10. JAMA. Editorial. JAMA 1942; 119: 1110.
11. MacNalty A. Acute infectious jaundice and administration of measles serum. Annals Report Chief Med. Officer (Ministry of health) 1937; London (HMSO).
12. Findlay G, MacCallum F, Murgatroyd F. Observation bearing on the etiology of infective hepatitis (so-called epidemic catarrhal jaundice). Trans R Soc Trop Med Hyg 1939; 32: 575-86.
13. Memorandum. Prepared by medical officiers of the ministry of Health. Homologous serum jaundice. Lancet 1943; 1: 83-8.
14. Beeson P, Chesney Y, McFarlan A. Hepatitis following injection of mumps convalescent plasma. I-use of plasma in the mumps epidemic. II-clinical and laboratory studies. Lancet 1944; 1: 814-8.
15. Truelove S, Hogben L. A documentary study of jaundice associated with syphilis treatment and blood transfusion. Br J Prevent Soc Med 1947; 1: 18-32.
16. Findlay G, Martin N, Mitchell J. Hepatitis after yellow fever inoculation. Relation to infective hepatitis. I. Clinical and pathological findings. II. Immunology and epidemiology. Lancet 1944; 2: 305-70.
17. McFarlan F, Chesney G. Hepatitis following injection of mumps convalescent plasma. II Epidemiology of the hepatitis. Lancet 1944; 1: 816-7.
18. Lépine P. Hépatites infectieuses. In: Techniques de Laboratoire en Virologie Humaine. Paris: Masson, 1964: 653-80.
19. Krugman S. The Willowbrook Hepatitis studies revisited. Ethical aspects. Rev Infect Dis 1986; 8: 157-62.
20. Lainer G. Zur Frage der Infecktiosität des Ikterus. Wien Klin Wochenschr 1940; 53: 601-4.
21. Voegt H. Zur aetiologie der hepatitis epidemica. Münch Medizinische Wochenschr 1942; 89: 76-9.
22. Cameron J. Infective hepatitis. Q J Med 1943; 12: 139-55.
23. MacCallum F, Bradley W. Transmission of infective hepatitis to human volunteers: Effect on rhumatoïd arthritis. Lancet 1944; 2: 228.
24. Havens W. Properties of the etiological agent of infectious hepatitis. Proc Soc Exp Biol Med 1945; 58: 203-4.
25. Havens W,JJR.W, Drill V et al. Experimental production of hepatitis by feeding icterigenic materials. Proc Soc Exp Biol Med 1944; 57: 206-8.
26. Havens W. Period of infectivity of patients with experimentally induced infections hepatitis. J Exp Med 1946; 83: 251-8.
27. Havens W. Period of infectivity of patients with homologous serum jaundice and routes of infection in this disease. J Exp Med 1946; 83: 441-7.
28. Neefe J, Stokes J, Reinhold J. Oral administration to volunteers of feces from patients with homologous serum hepatitis and infectious (epidemic) hepatitis. Am J Med Sci 1945; 210: 29-32.
29. MacCullum F. Homologous serum hepatitis. Lancet 1947; 2: 691-2.
30. Sherwood P. Outbreak of syring-transmitted hepatitis with jaundice in hospitalized diabetic patiens.Ann Intern Med 1950; 33: 380-96.
31. Hartfall S, Garland H, Goldie W. Gold treatment of arthritis. Lancet 1937; 1: 838-42.
32. OMS. Premier Rapport du Comité D'experts. Genève: Série des Rapports Techniques, 1953: 62.
33. Krugman S, Gilles J, Hammond J. Infectious hepatitis-Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967; 200: 365-73.